Fibrocystic Breast Diagnostics and Treatment Market Overview

The fibrocystic breasts diagnostics and treatment market is expected to register a significant growth during the forecast period (2020–2027).The worldwide fibrocystic breasts diagnostics and treatment Fibrocystic Breast Diagnostics and Treatment Market is estimated to record a substantial growth over the forecast period (2018–2023). Fibrocystic breasts are a non-cancerous disease characterized by round lumps which move freely within the breast tissue and normally swell and shrink with the onset and end of the menstrual cycle. It is projected that 40% of all women in North America are suffering from fibrocystic breast disease. Fibrocystic breast changes are common in women of ages 20- 50. Drinking alcohol may increase the risk of having fibrocystic breast, especially in young women between 18 to 22 years of age. The symptoms are lumps, cyclic breast pain, tenderness, and nipple discharge.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6448

 Market Segmentation

The worldwide fibrocystic breasts diagnostics and treatment market has been segmented based on end users and type. Based on type, the market has been segmented as treatment and diagnosis. Treatment is sub-segmented into fine-needle aspiration, medications, oral contraceptives, and surgical excision. The medications are further segmented into nonsteroidal anti-inflammatory drugs and acetaminophen. As per end users, the market has been segmented into hospitals, clinics, diagnostic centers, specialty clinics and rehab centers, research institutes, and others. Diagnosis is sub-segmented into breast biopsy and mammogram.

 Regional Analysis

Fibrocystic breasts diagnostics and treatment market Share, by Region, 2017 (%)

In the fibrocystic breast diagnostics and treatment market, North America is anticipated to account for largest market share due to the early adoption of advanced medical technologies, continuous development by companies operating into cancer diagnostic. More than half of women experience fibrocystic breast changes at some point in their lives. According to the American Cancer Society's evaluations, there are chances of around 266,120 new cases of breast cancer may be identified only in 2018 and about 40,920 women may die due to breast cancer.

The European market is expected to hold the second largest market share. The market growth in this region can be attributed to increasing amount of alcohol consumption by women, changes in estrogen levels due to increase in intake of birth control pills and increasing use of hormone replacement therapy (HRT) are boosting the European market.

Whereas the market share in Asia-Pacific region is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increasing government initiatives and rising healthcare expenditure.

The market in the Middle East Africa is expected to account for the smallest share of the global fibrocystic breast diagnostics and treatment market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

 Market Players

• Allergan plc,
• Teva Pharmaceutical Industries Ltd,
• Hologic, Inc.,
• Bayer AG,
• Merck Co., Inc.,
• Pfizer Inc
• Gallini Medical Devices.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/fibrocystic-breasts-diagnostics-treatment-market-6448

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com